Browse TRPV1

Summary
SymbolTRPV1
Nametransient receptor potential cation channel, subfamily V, member 1
Aliases vanilloid receptor subtype 1; OTRPC1; capsaicin receptor; osm-9-like TRP channel 1; transient receptor poten ......
Chromosomal Location17p13.2
External Links HGNC, NCBI, Ensembl, Uniprot, GeneCards
Content Basic function annotation.
> Subcellular Location, Domain and Function
> Gene Ontology
> KEGG and Reactome Pathway
> Subcellular Location, Domain and Function
 
Subcellular Location Cell junction, synapse, postsynaptic cell membrane Multi-pass membrane protein Cell projection, dendritic spine membrane Multi-pass membrane protein Cell membrane Multi-pass membrane protein Note=Mostly, but not exclusively expressed in postsynaptic dendritic spines.
Domain PF12796 Ankyrin repeats (3 copies)
PF00520 Ion transport protein
Function

Ligand-activated non-selective calcium permeant cation channel involved in detection of noxious chemical and thermal stimuli. Seems to mediate proton influx and may be involved in intracellular acidosis in nociceptive neurons. Involved in mediation of inflammatory pain and hyperalgesia. Sensitized by a phosphatidylinositol second messenger system activated by receptor tyrosine kinases, which involves PKC isozymes and PCL. Activation by vanilloids, like capsaicin, and temperatures higher than 42 degrees Celsius, exhibits a time- and Ca(2+)-dependent outward rectification, followed by a long-lasting refractory state. Mild extracellular acidic pH (6.5) potentiates channel activation by noxious heat and vanilloids, whereas acidic conditions (pH <6) directly activate the channel. Can be activated by endogenous compounds, including 12-hydroperoxytetraenoic acid and bradykinin. Acts as ionotropic endocannabinoid receptor with central neuromodulatory effects. Triggers a form of long-term depression (TRPV1-LTD) mediated by the endocannabinoid anandamine in the hippocampus and nucleus accumbens by affecting AMPA receptors endocytosis.

> Gene Ontology
 
Biological Process GO:0001659 temperature homeostasis
GO:0001660 fever generation
GO:0001696 gastric acid secretion
GO:0001774 microglial cell activation
GO:0002021 response to dietary excess
GO:0002024 diet induced thermogenesis
GO:0002274 myeloid leukocyte activation
GO:0002526 acute inflammatory response
GO:0002790 peptide secretion
GO:0003012 muscle system process
GO:0003014 renal system process
GO:0006809 nitric oxide biosynthetic process
GO:0006816 calcium ion transport
GO:0006820 anion transport
GO:0006835 dicarboxylic acid transport
GO:0006874 cellular calcium ion homeostasis
GO:0006875 cellular metal ion homeostasis
GO:0006936 muscle contraction
GO:0006939 smooth muscle contraction
GO:0006953 acute-phase response
GO:0007204 positive regulation of cytosolic calcium ion concentration
GO:0007586 digestion
GO:0007588 excretion
GO:0007635 chemosensory behavior
GO:0009266 response to temperature stimulus
GO:0009268 response to pH
GO:0009408 response to heat
GO:0009581 detection of external stimulus
GO:0009582 detection of abiotic stimulus
GO:0009991 response to extracellular stimulus
GO:0010447 response to acidic pH
GO:0010721 negative regulation of cell development
GO:0014047 glutamate secretion
GO:0014074 response to purine-containing compound
GO:0014832 urinary bladder smooth muscle contraction
GO:0014848 urinary tract smooth muscle contraction
GO:0015711 organic anion transport
GO:0015833 peptide transport
GO:0016048 detection of temperature stimulus
GO:0019233 sensory perception of pain
GO:0022600 digestive system process
GO:0031649 heat generation
GO:0031667 response to nutrient levels
GO:0032844 regulation of homeostatic process
GO:0032845 negative regulation of homeostatic process
GO:0033198 response to ATP
GO:0033555 multicellular organismal response to stress
GO:0034605 cellular response to heat
GO:0034612 response to tumor necrosis factor
GO:0042116 macrophage activation
GO:0042886 amide transport
GO:0043279 response to alkaloid
GO:0043434 response to peptide hormone
GO:0044057 regulation of system process
GO:0044058 regulation of digestive system process
GO:0044236 multicellular organism metabolic process
GO:0044708 single-organism behavior
GO:0045428 regulation of nitric oxide biosynthetic process
GO:0045429 positive regulation of nitric oxide biosynthetic process
GO:0046209 nitric oxide metabolic process
GO:0046683 response to organophosphorus
GO:0046717 acid secretion
GO:0046942 carboxylic acid transport
GO:0048265 response to pain
GO:0048266 behavioral response to pain
GO:0048871 multicellular organismal homeostasis
GO:0050907 detection of chemical stimulus involved in sensory perception
GO:0050951 sensory perception of temperature stimulus
GO:0050954 sensory perception of mechanical stimulus
GO:0050955 thermoception
GO:0050960 detection of temperature stimulus involved in thermoception
GO:0050961 detection of temperature stimulus involved in sensory perception
GO:0050965 detection of temperature stimulus involved in sensory perception of pain
GO:0050968 detection of chemical stimulus involved in sensory perception of pain
GO:0051047 positive regulation of secretion
GO:0051208 sequestering of calcium ion
GO:0051209 release of sequestered calcium ion into cytosol
GO:0051235 maintenance of location
GO:0051238 sequestering of metal ion
GO:0051259 protein oligomerization
GO:0051260 protein homooligomerization
GO:0051262 protein tetramerization
GO:0051282 regulation of sequestering of calcium ion
GO:0051283 negative regulation of sequestering of calcium ion
GO:0051289 protein homotetramerization
GO:0051480 regulation of cytosolic calcium ion concentration
GO:0055074 calcium ion homeostasis
GO:0060073 micturition
GO:0060083 smooth muscle contraction involved in micturition
GO:0060401 cytosolic calcium ion transport
GO:0060402 calcium ion transport into cytosol
GO:0060453 regulation of gastric acid secretion
GO:0060454 positive regulation of gastric acid secretion
GO:0060456 positive regulation of digestive system process
GO:0060856 establishment of blood-brain barrier
GO:0070509 calcium ion import
GO:0070588 calcium ion transmembrane transport
GO:0070838 divalent metal ion transport
GO:0071214 cellular response to abiotic stimulus
GO:0071312 cellular response to alkaloid
GO:0071318 cellular response to ATP
GO:0071356 cellular response to tumor necrosis factor
GO:0071407 cellular response to organic cyclic compound
GO:0071417 cellular response to organonitrogen compound
GO:0071467 cellular response to pH
GO:0071468 cellular response to acidic pH
GO:0071502 cellular response to temperature stimulus
GO:0072503 cellular divalent inorganic cation homeostasis
GO:0072507 divalent inorganic cation homeostasis
GO:0072511 divalent inorganic cation transport
GO:0072593 reactive oxygen species metabolic process
GO:0090210 regulation of establishment of blood-brain barrier
GO:0090212 negative regulation of establishment of blood-brain barrier
GO:0097553 calcium ion transmembrane import into cytosol
GO:0098657 import into cell
GO:0098659 inorganic cation import into cell
GO:0099587 inorganic ion import into cell
GO:1901594 response to capsazepine
GO:1901652 response to peptide
GO:1902656 calcium ion import into cytosol
GO:1903409 reactive oxygen species biosynthetic process
GO:1903426 regulation of reactive oxygen species biosynthetic process
GO:1903428 positive regulation of reactive oxygen species biosynthetic process
GO:1904407 positive regulation of nitric oxide metabolic process
GO:1990035 calcium ion import into cell
GO:1990089 response to nerve growth factor
GO:1990090 cellular response to nerve growth factor stimulus
GO:1990845 adaptive thermogenesis
GO:2000021 regulation of ion homeostasis
GO:2000377 regulation of reactive oxygen species metabolic process
GO:2000379 positive regulation of reactive oxygen species metabolic process
GO:2001057 reactive nitrogen species metabolic process
Molecular Function GO:0005216 ion channel activity
GO:0005217 intracellular ligand-gated ion channel activity
GO:0005230 extracellular ligand-gated ion channel activity
GO:0005231 excitatory extracellular ligand-gated ion channel activity
GO:0005261 cation channel activity
GO:0005262 calcium channel activity
GO:0005516 calmodulin binding
GO:0005543 phospholipid binding
GO:0015085 calcium ion transmembrane transporter activity
GO:0015267 channel activity
GO:0015276 ligand-gated ion channel activity
GO:0015278 calcium-release channel activity
GO:0016247 channel regulator activity
GO:0017081 chloride channel regulator activity
GO:0022803 passive transmembrane transporter activity
GO:0022834 ligand-gated channel activity
GO:0022836 gated channel activity
GO:0022838 substrate-specific channel activity
GO:0035091 phosphatidylinositol binding
GO:0046873 metal ion transmembrane transporter activity
GO:0051219 phosphoprotein binding
GO:0072509 divalent inorganic cation transmembrane transporter activity
GO:0097603 temperature-gated ion channel activity
GO:0099604 ligand-gated calcium channel activity
Cellular Component GO:0009897 external side of plasma membrane
GO:0030425 dendrite
GO:0031252 cell leading edge
GO:0031253 cell projection membrane
GO:0031256 leading edge membrane
GO:0032589 neuron projection membrane
GO:0032590 dendrite membrane
GO:0032591 dendritic spine membrane
GO:0043025 neuronal cell body
GO:0044297 cell body
GO:0045211 postsynaptic membrane
GO:0097060 synaptic membrane
GO:0098552 side of membrane
GO:0098794 postsynapse
> KEGG and Reactome Pathway
 
KEGG hsa04080 Neuroactive ligand-receptor interaction
hsa04750 Inflammatory mediator regulation of TRP channels
Reactome R-HSA-983712: Ion channel transport
R-HSA-2672351: Stimuli-sensing channels
R-HSA-3295583: TRP channels
R-HSA-382551: Transmembrane transport of small molecules
Summary
SymbolTRPV1
Nametransient receptor potential cation channel, subfamily V, member 1
Aliases vanilloid receptor subtype 1; OTRPC1; capsaicin receptor; osm-9-like TRP channel 1; transient receptor poten ......
Chromosomal Location17p13.2
External Links HGNC, NCBI, Ensembl, Uniprot, GeneCards
Content Literatures that report relations between TRPV1 and anti-tumor immunity. The specific mechanism were also collected if the literature reports that a gene specifically promotes or inhibits the infiltration or function of T/NK cells.
> Text Mining
 
  Literatures describing the relation between TRPV1 and anti-tumor immunity in human cancer.
PMID Cancer type Relation to immunity Evidence sentences
29580868MelanomaPromote immunityAltogether, our study demonstrates that TRPV1 is a potential tumor suppressor in melanoma.
Summary
SymbolTRPV1
Nametransient receptor potential cation channel, subfamily V, member 1
Aliases vanilloid receptor subtype 1; OTRPC1; capsaicin receptor; osm-9-like TRP channel 1; transient receptor poten ......
Chromosomal Location17p13.2
External Links HGNC, NCBI, Ensembl, Uniprot, GeneCards
Content High-throughput screening data (e.g. CRISPR-Cas9, shRNA and RNAi) for T cell-mediated killing. Genetic screen techniques can identify mechanisms of tumor cell resistance (e.g., PTPN2) and sensitivity (e.g., APLNR) to killing by cytotoxic T cells, the central effectors of anti-tumor immunity. After comprehensively searching, eight groups of screening data sets were collected in the current database. In this tab, users can check whether their selected genes cause resistance or increase sensitivity to T cell-mediated killing in various data sets.
> High-throughput Screening
  Statistical results of TRPV1 in screening data sets for detecting immune reponses.
PMID Screening System Cancer Type Cell Line Data Set Statistical Results Relation to immunity
29301958CRISPR-Cas9 melanomaB16F10Pmel-1 T cell NA/NSNA/NS
29301958CRISPR-Cas9 melanomaB16F10OT-1 T cell NA/NSNA/NS
28783722CRISPR-Cas9 melanomaMel6242CT-CRISPR NA/NSNA/NS
28723893CRISPR-Cas9 melanomaB16GVAX+Anti-PD1 NA/NSNA/NS
28723893CRISPR-Cas9 melanomaB16GVAX NA/NSNA/NS
25691366RNAiBreast cancerMCF7Luc-CTL assay NA/NSNA/NS
24476824shRNAmelanomaB16Primary screen NA/NSNA/NS
24476824shRNAmelanomaB16Secondary screen NA/NSNA/NS
Summary
SymbolTRPV1
Nametransient receptor potential cation channel, subfamily V, member 1
Aliases vanilloid receptor subtype 1; OTRPC1; capsaicin receptor; osm-9-like TRP channel 1; transient receptor poten ......
Chromosomal Location17p13.2
External Links HGNC, NCBI, Ensembl, Uniprot, GeneCards
Content Transcriptomic and genomic profiling of pre-treated tumor biopsies from responders and non-responders to immunotherapy. These data were used to identify signatures and mechanisms of response to checkpoint blockade (e.g., anti-PDL1 and anti-PD1). One example is that mutations in the gene PBRM1 benefit clinical survival of patients with clear cell renal cell carcinoma. After comprehensively searching, we collected 5 and 6 of transcriptomic and genomic data sets, respectively. In this tab, users can check whether their selected genes have significant difference of expression or mutation between responders and non-responders in various data sets.
> Expression difference between responders and non-responders
> Mutation difference between responders and non-responders
> Expression difference between responders and non-responders
 
Points in the above scatter plot represent the expression difference of TRPV1 in various data sets.
No PMID Cancer type Group Drug # Res # NRes Log2 (Fold Change) P value Anno
126997480MelanomaallAnti-PD-1 (pembrolizumab and nivolumab)1412-0.2430.287
226997480MelanomaMAPKiAnti-PD-1 (pembrolizumab and nivolumab)65-0.8680.075
326997480Melanomanon-MAPKiAnti-PD-1 (pembrolizumab and nivolumab)870.2110.623
428552987Urothelial cancerallAnti-PD-L1 (atezolizumab) 9160.6290.0828
528552987Urothelial cancersmokingAnti-PD-L1 (atezolizumab) 590.2470.879
628552987Urothelial cancernon-smokingAnti-PD-L1 (atezolizumab) 471.120.616
729033130MelanomaallAnti-PD-1 (nivolumab) 26230.2820.329
829033130MelanomaNIV3-PROGAnti-PD-1 (nivolumab) 15110.7150.321
929033130MelanomaNIV3-NAIVEAnti-PD-1 (nivolumab) 1112-0.3090.738
1029301960Clear cell renal cell carcinoma (ccRCC)allAnti-PD-1 (nivolumab) 480.4870.377
1129301960Clear cell renal cell carcinoma (ccRCC)VEGFRiAnti-PD-1 (nivolumab) 2001
1229301960Clear cell renal cell carcinoma (ccRCC)non-VEGFRiAnti-PD-1 (nivolumab) 281.2510.0828
1329443960Urothelial cancerallAnti-PD-L1 (atezolizumab) 682300.0650.523
> Mutation difference between responders and non-responders
 
Points in the above scatter plot represent the mutation difference of TRPV1 in various data sets.
No PMID Cancer type Group Drug # Res # NRes % Mut/Res % Mut/NRes % Diff (R vs NR) Pval Anno
125765070Non-small cell lung cancer (NSCLC)allAnti-PD-1 (pembrolizumab) 14170001
225765070Non-small cell lung cancer (NSCLC)smokingAnti-PD-1 (pembrolizumab) 1030001
325765070Non-small cell lung cancer (NSCLC)non-smokingAnti-PD-1 (pembrolizumab) 4140001
426359337MelanomaallAnti-CTLA-4 (ipilimumab) 277301.4-1.41
526359337MelanomaBRAFiAnti-CTLA-4 (ipilimumab) 0140001
626359337Melanomanon-BRAFiAnti-CTLA-4 (ipilimumab) 275901.7-1.71
726997480MelanomaallAnti-PD-1 (pembrolizumab and nivolumab)21170001
826997480MelanomaMAPKiAnti-PD-1 (pembrolizumab and nivolumab)860001
926997480Melanomanon-MAPKiAnti-PD-1 (pembrolizumab and nivolumab)13110001
1028552987Urothelial cancerallAnti-PD-L1 (atezolizumab) 9160001
1128552987Urothelial cancersmokingAnti-PD-L1 (atezolizumab) 590001
1228552987Urothelial cancernon-smokingAnti-PD-L1 (atezolizumab) 470001
1329033130MelanomaallAnti-PD-1 (nivolumab) 38272.602.61
1429033130MelanomaNIV3-PROGAnti-PD-1 (nivolumab) 22130001
1529033130MelanomaNIV3-NAIVEAnti-PD-1 (nivolumab) 16146.206.21
1629301960Clear cell renal cell carcinoma (ccRCC)allAnti-PD-1 (nivolumab) 11139.109.10.458
1729301960Clear cell renal cell carcinoma (ccRCC)VEGFRiAnti-PD-1 (nivolumab) 610001
1829301960Clear cell renal cell carcinoma (ccRCC)non-VEGFRiAnti-PD-1 (nivolumab) 512200200.294
Summary
SymbolTRPV1
Nametransient receptor potential cation channel, subfamily V, member 1
Aliases vanilloid receptor subtype 1; OTRPC1; capsaicin receptor; osm-9-like TRP channel 1; transient receptor poten ......
Chromosomal Location17p13.2
External Links HGNC, NCBI, Ensembl, Uniprot, GeneCards
Content Relations between abundance of tumor-infiltrating lymphocytes (TILs) and expression, copy number, methylation, or mutation of TRPV1. The immune-related signatures of 28 TIL types from Charoentong's study, which can be viewed in the download page. For each cancer type, the relative abundance of TILs were inferred by using gene set variation analysis (GSVA) based on gene expression profile. In this tab, users can examine which kinds of TILs might be regulated by the current gene.
> Lymphocyte
 
Summary
SymbolTRPV1
Nametransient receptor potential cation channel, subfamily V, member 1
Aliases vanilloid receptor subtype 1; OTRPC1; capsaicin receptor; osm-9-like TRP channel 1; transient receptor poten ......
Chromosomal Location17p13.2
External Links HGNC, NCBI, Ensembl, Uniprot, GeneCards
Content Relations between three kinds of immunomodulators and expression, copy number, methylation, or mutation of TRPV1. These immunomo-dulators were collected from Charoentong's study. In this tab, users can examine which immunomodulators might be regulated by TRPV1.
> Immunoinhibitor
> Immunostimulator
> MHC molecule
> Immunoinhibitor
 
> Immunostimulator
 
> MHC molecule
 
Summary
SymbolTRPV1
Nametransient receptor potential cation channel, subfamily V, member 1
Aliases vanilloid receptor subtype 1; OTRPC1; capsaicin receptor; osm-9-like TRP channel 1; transient receptor poten ......
Chromosomal Location17p13.2
External Links HGNC, NCBI, Ensembl, Uniprot, GeneCards
Content Relations between chemokines (or receptors) and expression, copy number, methylation, or mutation of TRPV1. In this tab, users can examine which chemokines (or receptors) might be regulated by the current gene.
> Chemokine
> Receptor
> Chemokine
 
> Receptor
 
Summary
SymbolTRPV1
Nametransient receptor potential cation channel, subfamily V, member 1
Aliases vanilloid receptor subtype 1; OTRPC1; capsaicin receptor; osm-9-like TRP channel 1; transient receptor poten ......
Chromosomal Location17p13.2
External Links HGNC, NCBI, Ensembl, Uniprot, GeneCards
Content Distribution of TRPV1 expression across immune and molecular subtypes.
> Immune subtype
> Molecular subtype
> Immune subtype
 
> Molecular subtype
 
Summary
SymbolTRPV1
Nametransient receptor potential cation channel, subfamily V, member 1
Aliases vanilloid receptor subtype 1; OTRPC1; capsaicin receptor; osm-9-like TRP channel 1; transient receptor poten ......
Chromosomal Location17p13.2
External Links HGNC, NCBI, Ensembl, Uniprot, GeneCards
Content Associations between TRPV1 and clinical features.
> Overall survival analysis
> Cancer stage
> Tumor grade
> Overall survival
 
> Stage
 
> Grade
 
Summary
SymbolTRPV1
Nametransient receptor potential cation channel, subfamily V, member 1
Aliases vanilloid receptor subtype 1; OTRPC1; capsaicin receptor; osm-9-like TRP channel 1; transient receptor poten ......
Chromosomal Location17p13.2
External Links HGNC, NCBI, Ensembl, Uniprot, GeneCards
Content Drugs targeting TRPV1 collected from DrugBank database.
> Drugs from DrugBank database
 

  Details on drugs targeting TRPV1.
ID Name Drug Type Targets #Targets
DB00132Alpha-Linolenic AcidSmall MoleculeELOVL4, FADS1, FADS2, NR1H4, PPARA, PPARD, PPARG, RXRA, SLC8A1, TR ......10
DB00159IcosapentSmall MoleculeACSL3, ACSL4, FADS1, FFAR1, PPARA, PPARD, PPARG, PTGS1, PTGS2, SLC ......11
DB00168AspartameSmall MoleculeTAS1R2, TAS1R3, TRPV13
DB00316AcetaminophenSmall MoleculeFAAH, GSTP1, PTGS1, PTGS2, TRPV15
DB02955Ricinoleic AcidSmall MoleculeCNR1, CNR2, TRPV13
DB06515ResiniferatoxinSmall MoleculeTRPV11
DB06774CapsaicinSmall MoleculePHB2, TRPV12
DB09061CannabidiolSmall MoleculeCACNA1G, CACNA1H, CACNA1I, CHRNA7, CNR1, CNR2, GLRA1, GLRA1, GLRA3 ......25
DB09120ZucapsaicinSmall MoleculeTRPV11
DB09288PropacetamolSmall MoleculeCNR1, PTGS1, PTGS2, TRPV14
DB11131Capsicum oleoresinBiotechTRPV11